One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood-2018-99-118287
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 14 |
Affiliation: Memorial Sloan Kettering Cancer Center, The Ohio State University, Oregon Health & Science University, University of Maryland, Baltimore, University of Chicago, The University of Texas Southwestern Medical Center, Huntsman Cancer Institute, Emory University, Leukemia and Lymphoma Society, State Library of OhioEnasidenib Is Highly Active in Previously Untreated IDH2 Mutant AML: Early Results from the Beat AML Master Trial
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
